SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,515 | +21.0% | 3,733 | +14.3% | 0.01% | +40.0% |
| Q2 2023 | $373,907 | +71.5% | 3,265 | +155.7% | 0.01% | +25.0% |
| Q4 2020 | $218,000 | +3.8% | 1,277 | -14.2% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +556.2% | 1,489 | +365.3% | 0.00% | +300.0% |
| Q1 2020 | $32,000 | -23.8% | 320 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $42,000 | +68.0% | 327 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | -50.0% | 329 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $50,000 | +19.0% | 328 | -7.9% | 0.00% | 0.0% |
| Q1 2019 | $42,000 | -17.6% | 356 | -23.6% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +1175.0% | 466 | +370.7% | 0.00% | – |
| Q3 2017 | $4,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |